HF Collaboratory
@hfcollaboratory
The Heart Failure Collaboratory is an academic consortium of stakeholders committed to improving the eco-system of heart failure research.
New in @JACCJournals — an analysis led by #HFC members Michael Zile & @miltonpacker evaluates the effects of #Tirzepatide and the relationships between BMI, central adiposity and Weight loss in patients with obesity-related with #HFpEF jacc.org/doi/10.1016/j.… #heartfailure

Our #HFC members always contributing to the field! @FudimMarat 👏🏼👏🏼👏🏼
In a new video with @HCPLiveNews, DCRI’s @FudimMarat discusses the rising prevalence of GLP-1 RAs for heart failure, the value of remote patient monitoring, and exciting new HF treatments on the horizon. Watch here: hcplive.com/view/glp-1-ras…
👏🏼👏🏼👏🏼👏🏼
We are pleased to announce the launch of a new Grand Rounds presentation series featuring distinguished faculty from the Baim Institute. These sessions will be held monthly and will continue through 2026.
#HFC member @dranulala shares key insights on findings linking iron deficiency anemia w/ reduced peak VO2 on CPET in LVAD patients. #heartfailure #lvad #cardiotwitter #cardiologyresearch #heartfailurecollaboratory
Is iron deficiency anemia associated w/ exercise capacity in patients with LVADs? 🏃 Check out a quick take by @dranulala on a new JCF Brief Report exploring the link between iron deficiency anemia and pVO₂ on CPET. Dive deeper into the study here: bit.ly/4l0XXJe
LIVE from @BaimInstitute ! Grand Rounds begins Monday, August 4th at 9:30 AM ET and features Dr. Javed Butler @JavedButler1 who will discuss Obesity Treatment and Heart Failure Everyone welcome to join & ask questions ! Zoom link: us06web.zoom.us/j/84539156716
Health inequities didn’t happen overnight — they’re rooted in history. A must-read article by #HFC member @NMHheartdoc highlights the importance of science as the foundation for action against inequities. ahajournals.org/doi/10.1161/CI… #heartfailure #cardiotwitter @mfiuzat @coconnormd
Congratulations @ankeetbhatt ! Your work continues to drive meaningful impact in #heartfailure care! So proud to have you as an #HFC member! 👏🏼
Honored to have been featured in the @GMedPhysicians Evidence in Action series, presentin a clinical case based on the latest research in heart failure. A great opportunity to support peer-to-peer learning and global clinical dialogue. #ClinicalCase #HeartFailure
Important insights from #HFC members @mvaduganathan @scottdsolomon @akshaydesaimd & colleagues- moving closer to personalized care in HFpEF and AF #heartfailure #finerenone #CardioTwitter #cardiology #heartfailurecollaboratory
Finerenone was effective in heart failure patients with mildly reduced or preserved ejection fraction, regardless of atrial fibrillation (AF) status, and new-onset AF was linked to higher risk of adverse outcomes. ja.ma/44IgNOA @HFpEF @AdriaanVoors @mvaduganathan
Out now — an analysis led by our #HFC members, the first to evaluate the inclusion of social determinants of health (SDOH) in clinical trials and to propose a lean approach to SDOH incorporation into trial data. @EMDeFilippisMD sciencedirect.com/science/articl…

Bravo @robmentz proud beyond words 👏🏼👏🏼👏🏼
The Legendary Rob Mentz from @DukeCardiology and co-editor of @JCardFail took the stage at the #CharlestonHFpEF Conference to tackle diuretics & decongestion—leading us through TRANSFORM like only he can. A fluid talk, in every sense. 💧 “How much diuretic do I give? Answer:…
We extend our heartfelt congratulations to Dr. Christopher O’Connor and Dr. Clyde Yancy on receiving the Lifetime Achievement Award at #hfm2025 presented by UF Health. We’re proud to see #HFC members celebrated for their enduring impact on the field. #heartfailure #Cardiology

Leadership in motion... Today and tomorrow (July 19-20) at #HFManagement2025, #HFC members continue to lead vital conversations on the evolving landscape of heart failure care — from clinical innovation to patient-centered strategies #hfm2025 Check the agenda for full details.


TODAY! Friday, July 18: -Managing Hyperkalemia in Heart Failure: Implementing Strategies to Reduce Patient Risk- at the 2025 Heart Failure Management Conference in Fernandina Beach, join us for a #cme program from 12:30-1:30 PM ET LIVE at youtube.com/@cmeplanet #hfm2025 #hf
Endlessly working on advancing heart failure care #hfc #heartfailure #Cardiology
In this analysis from @hfcollaboratory, we looked at the collection of SDOH in HF clinical trials and proposed a SDOH lean CRF for use moving forward. Full paper now in @JACCJournals #JACCHF ➡️ sciencedirect.com/science/articl… 🧵to follow
Big day at #HFManagement2025 Today’s sessions feature #HFC members at the forefront of heart failure innovation. Check out the agenda for full details! #heartfailurecollaboratory #heartfailure #medicalexcellence #cardiology #cardiotwitter


While there is increasing interest in using PROs as end points in #HeartFailure trials, there are barriers to successfully implementing this. Read more in this recent review article including @AllianceCardio Executive Committee Co-Chair @JavedButler1: ahajournals.org/doi/full/10.11…
Proud of our #HFC members’ outstanding work! Bravo Dr. @ankeetbhatt 👏🏼👏🏼👏🏼
Dr. @ankeetbhatt offers perspective on implementation science, “the scientific study of methods and strategies that facilitate the uptake of evidence-based practice and research into regular use by practitioners and policymakers." bit.ly/3oGbHeU #TransformCVCare
👏🏼👏🏼👏🏼👏🏼
Just 5 years ago, HFpEF was described as the “stepchild” of HF with no approved therapies. Today, there are 5 US FDA therapies: ✅ Empagliflozin (#EMPEROR) ✅ Dapagliflozin (#DELIVER) ✅ Sotagliflozin (#SOLOISTWHF) ✅ Sacubitril/Valsartan (#PARAGONHF) ✅ Finerenone (#FINEARTSHF)